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Telomerase transcriptional element-interacting
factor58-kDa microspherule protein (MSP58) plays an important role in a variety of cellular processes including tran-
scriptional regulation, cell proliferation and oncogenic transformation. Currently, themechanismsunderlying the
oncogenic effect of MSP58 are not fully understood. The human telomerase reverse transcriptase (hTERT) gene,
which encodes an essential component for telomerase activity that is involved in cellular immortalization and
transformation, is strictly regulated at the gene transcription level. Our previous study revealed a novel function
ofMSP58 in cellular senescence. Here we identify telomerase transcriptional element-interacting factor (TEIF) as
a novel MSP58-interacting protein and determine the effect of MSP58 on hTERT transcription. This study thus
provides evidence showing MSP58 to be a negative regulator of hTERT expression and telomerase activity.
Luciferase reporter assays indicated thatMSP58 could suppress the transcription ofhTERTpromoter. Additionally,
stable overexpression of MSP58 protein in HT1080 and 293T cells decreased both endogenous hTERT expression
and telomerase activity. Conversely, their upregulationwas induced byMSP58 silencing. Chromatin immunopre-
cipitation assays showed that MSP58 binds to the hTERT proximal promoter. Furthermore, overexpression of
MSP58 inhibited TEIF-mediated hTERT transactivation, telomerase activation, and cell proliferation promotion.
The inhibitory effect of MSP58 occurred through inhibition of TEIF binding to DNA. Ultimately, the HT1080-
implanted xenograft mouse model conﬁrmed these cellular effects. Together, our ﬁndings provide new insights
into both the biological function of MSP58 and the regulation of telomerase/hTERT expression.
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Telomerase is a ribonucleoprotein complexwith reverse-transcriptase
enzymatic activity which is responsible for adding hexameric repeats
(TTAGGG) to telomeric ends of linear chromosomes [1]. The human
core telomerase enzyme consists of a catalytic subunit (human telome-
rase reverse transcriptase; hTERT)which bears the enzymatic activity of
telomerase and an RNA moiety (human telomerase RNA; hTR) that is
used as a template for telomeric repeat synthesis [2]. Maintenance of
telomere lengths by telomerase is required for cells to be able to prolif-
erate indeﬁnitely and to escape from replicative senescence. In adult
humans, telomerase is present in human stem cells and germ cells but
is barely detectable in the vast majority of differentiated somatic cells
[3]. However, telomerase can be reactivated in most cancers and not
only stabilize their telomere size but also directly regulate multiple
cancer-promoting pathways [4]. Activation of telomerase is a critical
step during cellular immortalization and malignant transformation [5].
Notably, telomerase or hTERT reactivation is detected in up to 90%
of human cancers [6]. Moreover, it has been shown that ectopic
expression of hTERT can restore telomerase activity in many telomerase-
negative cell types, thereby facilitating immortalization [7,8]. Further-
more, introduction of a dominant negative form of hTERT or an anti-
sense vector targeted against hTERT inhibits telomerase activity in
human cancer cells and eventually induces apoptosis or differentiation
[9]. Therefore, hTERT expression is deﬁned as the rate-limiting factor in
regulating telomerase activity and is a hallmark of cancer.
Numerous studies suggest that telomerase enzymatic activity and
expressions of telomerase components are regulated at multiple levels,
including transcription and post-transcription, and by chaperone-
mediated folding and proper localization; however, the major control
mechanism of telomerase regulation seems to be at the level of hTERT
transcription [10]. Deletion analyses in reporter assays showed that
the approximately 200-bp proximal region of the hTERT promoter is im-
portant for maintaining basal transcriptional activity [11,12]. The hTERT
promoter contains several putative transcription factor-binding sites,
including c-Myc [13–15], Sp1 [11,12], E2F [16], USF [17], hypoxia-
inducible factor (HIF)-1 [18], and TCF4 [19]. Additional studies have
demonstrated that PI3K [20], NFAT [21], HMGA2 [22], the Bmi-1 onco-
gene [23], and the papillomavirus E6 protein [24] can also stimulate
hTERT promoter expression. In contrast, WT1 [25], Mad1 [26], MZF-2
[27], NFX1 [28], Smad3 [29], menin [30], and p53 [31,32] can negatively
regulate hTERT promoter expression. Distinct repression and activation
mechanisms likely operate in different cell contexts. For example, estro-
gen upregulates telomerase in both mammary and ovarian epithelial
cells [33,34]; IRF-4 and IRF-8, two lymphoid cell-speciﬁc transcription
factors, activate hTERT transcription in immune cells [35]; and E2F-1
has opposing actions toward hTERT gene expression in human tumors
and normal somatic cells [16,36]. Epigenetic regulatory mechanisms,
such as promoter DNA methylation [37] and histone acetylation [38],
also modulate hTERT expression.
The 58-kDa microspherule protein (MSP58, also known as MCRS1)
was originally identiﬁed as the interaction partner of the p120 nucleolar
protein [39]. Further studies showed that in nuclei and nucleoli, MSP58
functions to regulate transcription through its interactions with the
transcription factors Daxx, STRA13, and UBF [40–42]. Interestingly,
microspherule protein 2 (MCRS2) was identiﬁed as an interacting
partner of a potent inhibitor of telomerase, LPTS/PinX1, and hTERT
[43]. MCRS2 inhibits telomerase activity in vitro and long-term overex-
pression of MCRS2 in cancer cell lines leads to telomere shortening.
Drosophila MCRS2 is co-puriﬁed with RNA polymerase II complexes
and is required for normal levels of cyclin gene expression [44]. Notably,
MSP58 and MCRS2 have been shown to be associated with several
chromatin-remodeling complexes including Mi-2β (a component of
the NuRD complex), INO80, Brg1 (a subunit of the SWI/SNF complex),
and histone acetyltransferase males absent on the ﬁrst (MOF)
[42,45–48]. Furthermore, p78, an isoform of MSP58, has been identiﬁedas a centrosomal protein that is required for maintaining centrosome
homeostasis [49,50]. Importantly, a number of studies have indicated
that MSP58 plays a key role in oncogenesis. For instance, MSP58 and
TOJ3 (a quail homologue of MSP58) behave as oncogenes in ﬁbroblast
transformation assays, whereas the tumor suppressor, phosphatase
and tensin homologue (PTEN), suppresses the transforming activity of
MSP58 [51,52].
In a previous study, we demonstrated that MSP58 induces cellular
senescence through the p53/p21 pathway [48]. Identifying potential
novel binding partner(s) of MSP58 may help elucidate the role it plays
in controlling cell proliferation; to do this, we performed yeast two-
hybrid screening using MSP58 as bait. We identiﬁed a novel MSP58-
interacting protein, telomerase transcriptional element-interacting
factor (TEIF), that was found to bind to the hTERT promoter and acti-
vates its transcription and telomerase activities [53]. Notably, TEIF over-
expression has been detected in tumor tissues and cell lines, parallel to
hTERT [53,54]. In this study, we examined the potential contribution of
MSP58 to the transcriptional regulation of hTERT. Our data revealed
that overexpression of MSP58 repressed hTERT transcription and
telomerase activity, in part, through interaction with TEIF. Our ﬁndings
reveal MSP58 to be a negative regulator of hTERT expression and telo-
merase activity.
2. Materials and methods
2.1. Plasmids and antibodies
Yeast constructs expressing LexA-MSP58 and pGal-AD-TEIF, a mam-
malian vector expressing Flag-MSP58 and EGFP-MSP58, a pQCXIP-GFP-
MSP58 retroviral vector, and a bacterial vector expressing GST-MSP58
were as described previously [40,48,53]. MSP58 deletion mutants for
expressing LexA fusion in yeast and Flag-tagged fusion in mammalian
cells were generated by inserting polymerase chain reaction (PCR)
fragments respectively coding MSP58 amino acids 1–300 and 300–
462 into the pBTM116 and pCMV-Tag2 (Stratagene, La Jolla, CA, USA)
vectors. The full-length TEIF (amino acids 1–786) was cloned into the
pcDNA3.1-HA expression vector (Invitrogen) to generate HA-TEIF. The
TEIF and its deletion mutants for expressing Gal4 activation domain fu-
sion in yeast and HA-tagged fusion in mammalian cells were generated
by inserting PCR fragments respectively coding the full-length TEIF, and
amino acids 1–395 and 396–786 into the pACT2 (BD Biosciences
Clontech) and pcDNA3.1-HA vectors. Human Daxx complementary (c)
DNA was purchased from GeneCopoeia (Germantown, MD, USA). Full-
length Daxx was cloned into the pCDNA3.1-HA-expressing vector
(Invitrogen) to generate HA-Daxx. hTERT retrovirus vector pLPC-
hTERT (Clontech laboratories, CA, USA) was obtained from Dr. Yu-Ten
Ju (National Taiwan University, Taipei, Taiwan). Full-length hTERT
was cloned into the pCMV-Tag2 vector (Stratagene) to generate Flag-
hTERT. The hTERT promoter deletion mutants p548 (−548 to +50),
p212 (−212 to +50), p196 (−196 to +50), p177 (−177 to +50),
and p95 (−95 to +50) were cloned upstream of the ﬁreﬂy luciferase
reporter in the pGL3-Basic vector (Promega, Madison,WI, USA) follow-
ing a previously described protocol [55]. The luciferase reporter plas-
mid, TERTLuc800, as previously described [15], was a gift from Dr.
Kou-Juey Wu (National Yang-Ming University, Taipei, Taiwan). Short-
hairpin (sh)RNA targetingMSP58was expressed from the pLKO.1 hair-
pin vector, which harbors an expression cassette for a puromycin resis-
tance gene. shMSP58 sequences used were shMSP58 1: 5′-CCTGCGAT
TCGTCTTCCTTAT-3′ and shMSP58 2: 5′-CAACAACTCTGTGGTGGAGAT-
3′. pLKO.1-shLuc (TRCN0000072243; shLuc) was used as a control.
These vectors were obtained from The RNAi Consortium (TRC) library
(National RNAi Core Facility, Academia Sinica, Taipei, Taiwan). The
pSUPER vector expressing small-interfering (si)RNA of human MSP58
was constructed according to instructions from OligoEngine (Seattle,
WA, USA). The 19-nucleotide target sequences for siMSP58 were si-3
(5′-GAAGAAGAAGGTATCCAAA-3′) and si-5 (5′-CAAGGTGTCATCAAGC
567C.-C. Hsu et al. / Biochimica et Biophysica Acta 1843 (2014) 565–579TGA-3′). All plasmids were veriﬁed by restriction enzyme digestion and
DNA sequencing analyses. The rabbit MSP58 antibody was described
previously [48]. The following commercial antibodies were used in
this study: Flag (M2; Sigma, St. Louis, MO, USA), HA (HA.11; Babco/
Covance, Berkley, CA, USA), TEIF (653A; Bethyl Laboratories, Montgom-
ery, TX, USA). hTERT (Y182; GeneTex, San Antonio, TX, USA), Daxx
(D7810; Sigma), and actin (clone AC-74; Sigma).2.2. Cell culture, transfection, and viral production and infection
293T cells were cultured in Dulbecco's modiﬁed Eagle's medium
(DMEM; Invitrogen) supplemented with 10% fetal bovine serum
(FBS). HT1080 cells were maintained in minimum essential medium
(Invitrogen) with 10% FBS. All cells were maintained at 37 °C under a
5% CO2 atmosphere. Plasmids were transfected using PolyJet™ reagent
(SignaGen Laboratories, Gaithersburg,MD, USA). For stable transfection,
cells were selected with either 400 μg/ml neomycin (G418) or 2 μg/ml
puromycin. To create retroviral stocks, 293T cells were cotransfected
with the pQCXIP-GFP control or pQCXIP-GFP-MSP58 expression vector
and pCL-ampho packaging plasmid. To create lentiviral stocks, 293T
cells were co-transfected with the appropriate lentiviral expression
vector, pCMVΔR8.74 packaging vector, and pMD2 VSVG envelope
vector. Culture supernatants were harvested at 48 h post-transfection
and ﬁltered through a 0.45-μm ﬁlter, split into aliquots, and stored
at −80 °C. Infections were carried out overnight in the presence of
8 μg/ml polybrene (Sigma). Cells were subsequently selected for an-
tibiotic resistance (2 μg/ml puromycin and/or 400 μg/ml neomycin).2.3. Western blot, coimmunoprecipitation, immunoﬂuorescence, and
luciferase analyses
The complete protocols for the Western blot, coimmunopre-
cipitation, immunoﬂuorescence, and luciferase reporter analyses
were described previously [48]. For the reporter assays, cells were
cotransfected with TERTLuc800, hTERT-p548, hTERT-p212, hTERT-
p196, hTERT-p177, hTERT-p95, or Flag-MSP58 and the internal control
reporter pRL-TK. Cells were harvested at 48 h post-transfection, and
ﬁreﬂy luciferase activity was measured with the dual-luciferase
reporter assay system (Promega) and normalized against Renilla lucif-
erase activity. All experiments were performed at least three times
with each plasmid, and the mean relative luciferase activities were
determined.2.4. Isolation of RNA and real-time quantitative PCR (qPCR)
The detailed steps of RNA isolation and the reverse-transcription
(RT)-PCR were described previously [48,56]. The real-time qPCR was
performed using the SYBR Green Advantage qPCR Premix (Clontech)
and C1000™ Thermal Cycler (Bio-Rad Laboratories). PCRs were then
performed using the following conditions for 30 cycles: 95 °C for 30 s,
60 °C for 30 s, and 72 °C for 30 s. Values for hTERT were normalized
to the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) house-
keeping control. The following primer pairs were used: hTERT, forward
(5′-TGTTTCTGGATTTGCAGGTG-3′) and reverse (5′-GTTCTTGGCTTTCA
GGATGG-3′); and GAPDH, forward (5′-CCCACTCCTCCACCTTTGAC-3′)
and reverse (5′-TCTCTCTTCCTCTTGTGCTCTTG-3′).2.5. Focus-formation and soft-agar assays
Focus-formation and soft-agar assays of HT1080 or 293T cells over-
expressing HA-TEIF and GFP-MSP58 or MSP58 shRNAs were performed
by a method we described previously [48].2.6. Yeast two-hybrid screen and β-galactosidase assay
The LexA-MSP58 full-length bait construct was used to screen
against a human testis cDNA library (Clontech). Yeast two-hybrid
screening and analysis were performed as described previously [40].
2.7. Cell-free transcription and translation (TNT) and GST pull-down assays
The TEIF, Daxx, hTERT, MSP58 and its deletion mutants were
expressed in vitro using plasmids containing a T7 or SP6 promoter in
a rabbit reticulocyte lysate system (Promega). The expression and puri-
ﬁcation of GST and GST-MSP58 fusion proteins were performed as
described previously [40]. About 40 μg of TEIF proteins from a cell-
free transcription and translation system were incubated with 2 μg of
GST or GST-MSP58 fusion proteins in 0.2 ml of binding buffer (10 mM
Hepes (pH 7.5), 50 mMNaCl, 0.1% Nonidet P-40, 0.5 mMdithiothreitol,
and 0.5 mMEDTA) for 1–2 h, washed four times, and analyzed by sodi-
um dodecylsulfate (SDS)-polyacrylamide gel electrophoresis (PAGE)
and by Western blotting using an anti-HA antibody. A fraction of the
reaction mixture was analyzed by Coomassie blue staining to visualize
GST fusion proteins.
2.8. Assay for telomerase activity
For the telomerase activity analysis, protein extracts were prepared
using a CHAPS lysis buffer (10 mM Tris–HCl at pH 7.5, 1 mM MgCl2,
1 mM EGTA, 0.1 mM PMSF, 5 mM β-mercaptoethanol, 0.5% CHAPS,
and 10% glycerol) and then extracted for 30 min on ice. Extracts were
centrifuged at 13,000 ×g for 20 min, and the supernatants were collect-
ed. Supernatant extracts were quantiﬁed for protein with a BCA Protein
Assay Kit (Pierce Biotechnology, Rockford, IL, USA). The telomeric repeat
ampliﬁcation protocol (TRAP) assay was carried out as originally
described [4] with modiﬁcations [57,58]. Brieﬂy, each reaction was
carried out using 2 μl of cell lysate, 1 μl of each primer, 0.5 μl of Taq-
polymerase (New England BioLabs, Ipswich, MA, USA), 5 μl of a 10×
TRAP reaction buffer (200 mM Tris–HCl at pH 8.3, 15 mM MgCl2,
630 mM KCl, 0.5% Tween 20, and 10 mM EGTA), and 2 μl of dNTPs in
DEPC-treated water in a ﬁnal volume of 50 μl. Primers used for the
TRAP-assay PCR were the TS oligonucleotide (5′-AATCCGTCGAGCAG
AGTT-3′), which served as both the telomerase template and forward
primer for the PCR; the CXa oligonucleotide (5′-GTGTAACCCTAACCCT
AACCC-3′), which served as the reverse primer and the substrate for
the 36-bp internal standard control (ITAS; 5′-AATCCGTCGAGCAGAGTT
AAAAGGCCGAGAAGCGAT-3′); and the reverse primer (NT; 5′-ATCGCT
TCTCGGCCTTTT-3′) for ampliﬁcation of the internal standard control
(IC). The PCR program consisted of incubation at 30 °C for 30 min and
then 30 rounds of 94 °C for 2 min, 94 °C for 30 s, 55 °C for 30 s, and
72 °C for 1 min, with a ﬁnal extension at 72 °C for 2 min. TRAP products
were resolved using electrophoresis in 12.5% non-denaturing polyacryl-
amide gels (acrylamide/N,N′-methylenebisacrylamide, 19: 1, w/w) in
0.5× TBE (Tris-borate EDTA). Gels were stained with 5 μl of SYBR
Green (Lonza, Rockland, ME, USA) for 30 min in 50 ml of TBE 0.5×
buffer, then exposed to ultraviolet (UV) light, and visualized using a
Kodak image acquisition station.
2.9. Chromatin immunoprecipitation (ChIP) analysis
ChIP assays were performed as described previously [56]. Brieﬂy,
sheared chromatin fragments were immunoprecipitated with antibod-
ies speciﬁc to Flag, TEIF, or control immunoglobulin G (IgG) at 4 °C over-
night. After dissociating the DNAs from the immunoprecipitated
chromatin, the DNAs were PCR-ampliﬁed. The association of TEIF and
Flag-MSP58 with the hTERT promoter was measured with a nested
PCR using the following primers: outer primers, 5′-AGTGGATTCGCG
GGCACAGA-3′ (sense) and 5′-TTCCCACGTGCGCAGCAGGA-3′ (anti-
sense); and inner primers, 5′-TCCTGCCCCTTCACCTTCCAG-3′ (sense)
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was separated on 2% agarose gels and visualized by ethidium bromide
staining.
2.10. Electrophoretic mobility shift assay (EMSA)
TEIF and MSP58 proteins used in the EMSA were in vitro-translated
byusing a TNTquick coupled transcription–translation system (Promega)
according to themanufacturer's procedures. An EMSAwith biotin-labeled
probes was performed using the LightShift chemiluminescent EMSA kit
(Pierce Biotechnology). The 234-bp double-stranded probe of the
hTERT promoter was ampliﬁed by a PCR with a 5′-biotin-labeled or
5′-unlabeled primer and puriﬁed using the PCR-M Clean Up System
(Viogene, Taipei, Taiwan). The following speciﬁc primer pairs were
used: forward 5′-TTCACCTTCCAGCTCCGCCTCCTCCGCGCG-3′ (−144 to
−127) and reverse 5′-GAGCGCACGGCTCGGCAGCGGGGA-3′ (+90 to
+74). Biotin-labeled DNA fragments were incubated for 30 min on
ice with the in vitro-translated protein (2 μl) in EMSA binding buffer
(10 mM Tris at pH 7.5, 50 mM KCl, 1 mM DTT, 5% glycerol, 0.05%
NP-40, and 0.1 μg sheared salmon spermDNA). For the probe competi-
tion experiments, the TNT-TEIF protein was preincubatedwith an unla-
beled probe for 10 min at 4 °C before a 20-min incubation with the
biotin-labeled probe. For competition assays, in vitro-translated protein
of MSP58FL, MSP581–300, orMSP58300–462 (increasing volumes 2 to 4 μl)
were preincubated with the TEIF for 10 min followed by the addition of
the biotin-labeled probe. For the supershift assay, the TNT-TEIF recom-
binant protein was preincubated with an anti-HA antibody for 10 min
before the addition of the biotin-labeled probe. The reaction mixture
was loaded onto a 4% non-denaturing polyacrylamide gel, which was
run in 0.5× TBE buffer at 200 V for 2 h. The DNA–protein complex
was transferred to a nylon membrane and UV-crosslinked. The biotin
end-labeled DNA probe was detected using a streptavidin-horseradish
peroxidase conjugate and a chemiluminescent substrate.
2.11. Cell cycle analysis
Cells transfected and infected with the indicated plasmids were
trypsinized and washed with ice-cold PBS. After ﬁxation with 4 °C 75%
ethanol for 24 h, the cells were treated with 0.2 mg/ml RNase A
(Invitrogen™, Grand Island, NY) and stained with 20 μg/ml PI (Sigma-
Aldrich, St Louis, MO, USA) for 1 h at room temperature. To analyze
cell distribution in the cell cycle, PI-stained cells were analyzed by a
ﬂow cytometer (Beckman coulter Cell LabQuanta™ SCﬂow cytometry).
Data were analyzed with WinMDI 2.8 software.
2.12. Xenograft analysis
Twenty female athymic SCID mice (6–8 weeks of age) were pur-
chased from the National Laboratory Animal Center of National Cheng
Kung University in Taiwan. Themicewere housed in individually venti-
lated sterile cages. All cage accessories were sterilized and autoclaved
before they were placed in the cage. The animal experiment was
approved by the Institutional Animal Care and Use Committee atFig. 1. Effect of theMSP58 onhTERT expression and telomerase activity in 293T andHT1080 cell
MSP58 short-hairpin (sh)RNAs (shMSP58 1 and 2) or a luciferase control sequence (shLuc) and
blotting assays using antibodies against MSP58, hTERT, or actin. Right, MSP58 and hTERT expr
MSP58-overexpressing cells (clones 11 and 14). B, quantitative RT-PCR analysis of hTERTmRNA
tion with a control or Flag-MSP58 vector. Values for hTERTwere normalized to the GAPDH hous
as 1.0, and other values were accordingly normalized. Columns, mean of three independent ex
various hTERT promoter constructs used in this assay. Luc, luciferase. Numbers refer to the
hTERT gene. Relative luciferase activities (RLA) of extracts from HT1080 cells cotransfected with
(−800 to+1), p548 (−548 to+50), p212 (−212 to+50), p196 (−196 to+50), p177 (−177
to a luciferase assay. Results represent themean ± standard deviation from three independent
or p-196 reporter construct, pRL-TK, and the indicated amounts of MSP58-overexpressing (Flag
48 and 72 h post-transfection, respectively. MSP58 protein levels were assessed byWestern blo
independent experiments. *p b 0.05; **p b 0.01; ***p b 0.001. E, telomerase activity assayed by
cell lysates from the same experiments as in panel D. CHAPS lysis buffer for a negative controlNational Cheng Kung University. The mice were divided randomly into
four groups. Before implanting on Day 0, HT1080 GFP HA empty,
HT1080 GFP-MSP58 HA, HT1080 HA-TEIF GFP, and HT1080 GFP-MSP58
HA-TEIF cells were harvested and counted. The cells (2.5 × 106 cells)
were suspended in 0.1 ml of PBS, and then inoculated subcutaneously
into the back of mice (ﬁve mice for each group), which led to palpable
nodules on Day 8. The growth of tumors was measured with calipers
every two days from Day 8 to 23. The width (a) and length (b) of the
tumors were measured by calipers to evaluate tumor volume according
to the formula V = ba2/2. Mice were sacriﬁced on Day 24 and tumors
were collected tomeasure theirweight. ForWestern blot and telomerase
activity assays, tumor tissues were dissected after 24 days, quick-frozen
in dry ice, and stored at−80 °C.
2.13. Statistical analysis
Statistical comparisonswere performed using a two-tailed Student's
t-test. p values were calculated using the GraphPad Prism software vers.
3.03 package (GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Effects of MSP58 on TERT transcription and telomerase activity in
HT1080 and 293T cells
Our previous data showed that stable MSP58 overexpression in-
duced cellular senescence in HT1080 ﬁbrosarcoma cells [48]. Interest-
ingly, those cells displayed a marked reduction in telomerase activity.
We further demonstrated that MSP58 overexpression can also induce
senescence-associated growth arrest in 293T cells (Supplemental
Fig. 1A, B). In the previous report [43], it has been demonstrated that
MCRS2, a splice isoform of human MSP58, can associate with the
catalytic subunit hTERT of telomerase. Forced expression of MCRS2
inhibited telomerase activity in vitro. These ﬁndings suggest that
MSP58 inhibits telomerase activity might also through physical interac-
tion with hTERT protein. To examine this possibility, we investigated
the interaction between MSP58 and hTERT in vivo. HT1080 MSP58
stable clone (no.14) cell lysates were immunoprecipitated with anti-
Flag antibody, and Western blot analysis was performed with anti-
Daxx or hTERT antibody. Using a rabbit monoclonal antibody Y182,
we could detect the basal levels of hTERT protein in HT1080 cells and
other cancer cell lines (data not shown). Endogenous Daxx protein
could be coimmunoprecipitated by anti-Flag antibody but not by non-
speciﬁcmouse IgG (Supplemental Fig. 2A), consistentwith our previous
report [40]. In contrast, no appreciable interaction was detected
between Flag-MSP58 and hTERT (Supplemental Fig. 2A). Next, we ex-
amined the interaction between MSP58 and hTERT in vitro by GST
pull-down assay. In vitro transcriptional and translational lysates con-
taining full-length Daxx or hTERT protein were incubated with the
immobilized GST or GST-MSP58 fusion protein, analyzed by SDS-
PAGE, and detected by immunoblotting. A strong retention of Daxx pro-
tein, but not hTERT protein was obtained in the sample containing
immobilized GST-MSP58 (Supplemental Fig. 2B). These results ares. A, left; 293T andHT1080 cellswere infectedwith two independent lentiviruses encoding
then cultured at 37 °C for 3 days. Cell extracts were prepared and analyzed by immuno-
essions were also analyzed using immunoblotting in HT1080 parental, vector, and stably
in 293T and HT1080 cells 3 days after lentiviral shRNA transduction or transient transfec-
ekeeping control. The expression of hTERT in shLuc or Flag vector control cells was deﬁned
periments; bars, standard deviation. *p b 0.05; **p b 0.01. C, schematic representation of
number of bases upstream (−) or downstream (+) of the ATG initiation codon of the
the luciferase reporter plasmid containing hTERT promoter deletionmutants TERTLuc800
to+50), p95 (−95 to+50), and pRL-TK (internal control vector) for 24 hwere subjected
experiments. *p b 0.05. D, 293T and HT1080 cells were cotransfectedwith the TERTLuc800
-MSP58) or -knockdown (pSuper-MSP58 si-3) plasmids, followed by a luciferase assay at
tting. Column and error bars indicate themean ± standard deviation obtained from three
a telomeric repeat ampliﬁcation protocol as described under “Materials and methods” in
was included. The arrow points to the 36-bp internal control (IC).
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suggesting that MSP58 does not associate with hTERT. hTERT gene
expression is highly regulated and generally correlates with telomerase
activity. We further examined whether MSP58 can regulate hTERT
expression. To assess this, we silenced gene expression using lentivirus
particle carrying shRNA against MSP58 in the HT1080 and 293T cell
lines and then immunoblotted extracts for expressions of MSP58 and
hTERT. As shown in Fig. 1A (left panel), two different shRNAs against
MSP58 (1 and 2) induced increased the steady-state levels of hTERT
protein in both theHT1080 and 293T cell lines, compared to the controls
which expressed luciferase shRNA. In contrast, hTERT protein levels
decreased in both MSP58-overexpressing HT1080 stable cell lines
(clones 11 and 14) compared to control cells (Fig. 1A, right panel). Con-
sistently, MSP58 knockdowns, as shown by RT-qPCR analysis, upregu-
lated hTERT mRNA expression in both the HT1080 and 293T cell lines
(Fig. 1B). A similar decrease in hTERT mRNA expression was obtained
by transiently transfecting HT1080 and 293T cells with the MSP58 ex-
pression construct (Fig. 1B). The ﬁnding that MSP58 downregulates
hTERTmRNA suggests that hTERT expression is controlled by MSP58 at
the transcriptional level. To examine whether MSP58-mediated down-
regulation of hTERTmRNA is due to promoter repression, we performed
a series of hTERT promoter-luciferase gene reporter assays. As demon-
strated in Fig. 2C, MSP58 repressed transcriptional activities of the
TERTLuc800 (p800) [15], hTERT-p548, hTERT-p212, hTERT-p196,
hTERT-p177, and hTERT-p95 [55] constructs when cotransfected into
HT1080 cells. Furthermore, results showed that MSP58 reduced
TERTLuc800 and hTERT-p196 luciferase activities in a dose-dependent
manner in both HT1080 and 293T cells, while knockdown of MSP58 in-
creased the promoter activity (Fig. 1D). To examine the effects ofMSP58
overexpression on telomerase activity, we performed a TRAP assay.
Consistently, cells expressing MSP58 showed low levels of telomerase
activity in a dose-dependent manner (Fig. 1E). These data suggest
that MSP58 downregulates telomerase activity by inhibiting hTERT
expression.
3.2. Identiﬁcation of TEIF as a novel MSP58-interacting protein
To further identify MSP58-binding proteins that may be involved in
telomerase regulation and/or cellular senescence, we performed yeast
two-hybrid screening using the full-length of MSP58 as bait. One
positive clone encoding telomerase transcriptional element-interacting
factor (TEIF) cDNA was isolated from a Matchmaker human testis
cDNA library (data not shown). TEIF was ﬁrst identiﬁed as a protein
that binds to the hTERT promoter and acts as a positive modulator of
the hTERT gene [53]. To further verify the protein interaction between
MSP58 and TEIF in vitro, GST pull-down experiments were carried
out using the GST-MSP58 fusion protein and a battery of in vitro-
translated TEIF. As shown in Fig. 2A, the full-length TEIF was speciﬁcally
pulled down by GST-MSP58, but not by the GST protein. The interac-
tion between MSP58 and TEIF was further validated by co-immuno
precipitation assays in mammalian cells. Overexpressed MSP58 and
TEIF proteins were reciprocally coimmunoprecipitated in 293T cells
(Fig. 2B, top panel). Using another approach, endogenous TEIF pro-
teins were coimmunoprecipitated in the stable HT1080 MSP58-
overexpressing cell line (no. 11) by an anti-Flag antibody (Fig. 2B,
bottom panel). These results provided evidence that MSP58 andFig. 2.MSP58 interactswith the TEIF in vitro and in vivo. A, GST or GST-MSP58 fusion proteinsw
TEIF was obtained with a cell-free transcription and translation (TNT) system in vitro and incub
with an anti-HA antibody. B, coimmunoprecipitation assays. 293T cells were transfected with t
clone 11 cells were subjected to immunoprecipitation (IP) experiments followed by a Western
Flag-MSP58. Stars indicate the heavy chain of IgG. C, schematic presentation of wild-typeMSP58
hybrid assays. Numbers indicate the amino acid position. NLS, nuclear-localization signal; NoLS
kinase. D,mapping of theMSP58 and TEIF interaction domains. 293T cells co-transfectedwith H
jected to IP experiments followed by aWestern blot analysiswith the indicated antibodies. Arrow
chain of IgG. E, Yeast cotransformed with bait and prey as indicated were analyzed by quantita
periments. LexA-lamin served as a negative control.TEIF could form a complex in cells. Furthermore, we mapped the in-
teraction domain(s) using deletion derivatives of MSP58 and TEIF in
yeast two-hybrid assays and coimmunoprecipitation assays. As
shown in Fig. 2D and E, the results implied that the C-terminal region
of MSP58 (amino acids 300–462) was sufﬁcient to interact with TEIF,
and the C-terminal region of TEIF (amino acids 396–786) mediates
interaction with MSP58. These results suggest that MSP58maymod-
ulate hTERT transcription by directly interacting with TEIF.
3.3. Overexpression of MSP58 suppresses TEIF-mediated transactivation of
the TERT promoter and telomerase activity
Previous studies have demonstrated that TEIF transactivates hTERT
promoter activity [53]. We performed luciferase reporter assays to
elucidate whether MSP58 affects TEIF-mediated transcriptional activa-
tion of the hTERT promoter. The MSP58 expression construct was
cotransfected into 293T or HT1080 cells along with the TEIF expression
construct and TERTLuc800 reporter.We demonstrated that TEIF overex-
pression induced hTERT promoter activity that was two to three times
higher than the vector control (Fig. 3A). Overexpression of MSP58 itself
signiﬁcantly suppressed promoter activity. Also, overexpression of
MSP58 resulted in inhibition of luciferase activity activated by TEIF in
HT1080 and 293T cells in a dose-dependent fashion (Fig. 3A). Converse-
ly, compared to the control vector, both MSP58 shRNAs (si-3 and si-5)
signiﬁcantly elevated TEIF-mediated activation of the hTERT promoter
(Fig. 3A). Similar resultswere observed using the hTERT-p196 construct
(Fig. 3B). To establish a correlation between the MSP58/TEIF interac-
tion and the TEIF transcriptional repression by MSP58, the ability of
speciﬁc MSP58 deletion mutants to repress TEIF-mediated trans-
activation was analyzed. As illustrated in Fig. 3C, overexpression of
MSP58-(300–462), like full-length MSP58, was capable of suppressing
TEIF-mediated hTERT transcriptional activation, whereas MSP58-
(1–300) failed to do so, indicating that the C-terminal region of MSP58
was sufﬁcient for MSP58-mediated TEIF trans-repression. These data
provide direct evidence that the interaction between MSP58 and TEIF
was clearly correlated with MSP58's function as a TEIF trans-repressor.
Furthermore, we tested whether MSP58 could repress TEIF-mediated
activation of telomerase activity. As shown in Fig. 3D, telomerase activity
was activated by about 1.8 fold in 293T cells 48 h after TEIF transfection.
We also observed that knockdownof TEIF geneexpression by TEIF siRNA
inhibits telomerase activity in HT1080 cells (data not shown). Notably,
MSP58 suppressed TEIF-mediated enhancement of endogenous telome-
rase activity of 293T cells in a dose-dependent manner (Fig. 3D, left
panel). Consistently, telomerase activity was signiﬁcantly inhibited in
the TEIF-transfected HT1080 MSP58 clone 11 and 14 cells (Fig. 3D,
right panel) compared to the parental and vector control cells. Together,
these results suggest thatMSP58 serves as a negative regulator of TEIF in
controlling the hTERT promoter and telomerase activity.
3.4. MSP58 does not alter nuclear localization of the TEIF or hTERT
To elucidate themolecularmechanism underlyingMSP58-mediated
modulation of the TEIF transactivation potential and telomerase
activation, immunoﬂuorescence microscopic analyses were performed.
Because we previously reported that MSP58 can relieve the transcrip-
tional repressor activity of Daxx through a nucleolar sequestrationere expressed in Escherichia coli BL21 cells and immobilized on glutathione-Sepharose. The
ated with GST or GST-MSP58 proteins. Bound proteins were detected by immunoblotting
he indicated expression vectors. Whole-cell lysates (WCL) from 293T and HT1080 MSP58
blot analysis with the indicated antibodies. Arrows indicate the positions of HA-TEIF and
and TEIF, and different deletionmutants tested inmammalian transfection and yeast two-
, nucleolar-localization signal; FHA, forkhead-associated; STYKc, serine/threonine/tyrosine
A-TEIF and Flag-MSP58 full-length or deletionmutants of expression constructs were sub-
s indicate thepositions of HA-TEIF and Flag-MSP58. Stars indicate the heavy chain or light
tive β-Gal assays. Data represent the mean ± the standard deviation of three separate ex-
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could alter subcellular localization of TEIF or hTERT. As illustrated in
Fig. 4, 293T cells were transiently transfected with individual construct
or co-transfectedwith combinations of the EGFP-MSP58 andHA-tagged
TEIF or Flag-tagged hTERT constructs and subsequently stained with an
anti-HA or Flag antibody followed by an immunoﬂuorescence analysis.
Consistent with a previous report [53,59], TEIF and hTERT were pre-
dominantly localized in nuclei (Fig. 4E–H), while MSP58 was mostly
localized in nuclei and concentrated in nucleoli (Fig. 4A, B). In the con-
trol, the co-transfection of MSP58 drastically recruited Daxx protein
from the nucleoplasm tonucleoli in 293T cells (Fig. 4C, D, I–L). However,
overexpression of MSP58 did not alter nuclear staining of TEIF or hTERT
(Fig. 4M–T), suggesting that MSP58's repressive effect did not result
from alterations of TEIF or hTERT nuclear localization.
3.5. MSP58 prevents TEIF from binding to hTERT promoter DNA
Given MSP58's ability to bind to the C-terminal hTERT promoter
DNA-binding domain of TEIF, one possibility is that MSP58 represses
TEIF activity through direct interferencewith TEIF's DNA-binding capac-
ity. To test this hypothesis,we performed EMSAs. The in vitro-translated
full-length TEIF was incubated with a biotin-labeled hTERT promoter
DNA probe (Fig. 5A). The protein–DNA complexes were resolved by na-
tive PAGE. Clearly, the TEIF protein and hTERT probe formed a protein–
DNA complex, whereas the control vector did not form a visible com-
plex with the probe (Fig. 5B, left, lane 4 vs. lane 1). This protein–DNA
complex was speciﬁc, since formation of the complex could be
abolished by a 100 fold excess of the unlabeled hTERT oligonucleotide
(Fig. 5B, left, lane 5 vs. lane 4). Moreover, this complex could be further
supershiftedwhen an anti-HA antibodywas added (Fig. 5B, right, lane 8
vs. lane 9), indicating speciﬁc complex formation between the HA-TEIF
and hTERT. We next tested the effect of MSP58 on this complex forma-
tion. Remarkably, preincubation of the TEIF reaction mixture with
recombined wild-typeMSP58 protein prevented formation of the com-
plex of HA-TEIF with the hTERT probe in a dose-dependent fashion
(Fig. 5B, right, lanes 9–11). Of note,we found thatMSP58did not directly
bind to the hTERT promoter in vitro (Fig. 5B, left, lane 2), indicating that
its prevention of TEIF–hTERT probe complex formation was not due to
competition for hTERT promoter binding. Additionally, the C-terminal
region of MSP58 (300–462) more signiﬁcantly abrogated complex for-
mation between the TEIF and hTERT probe than did full-length MSP58
(Fig. 5B, right, lanes 14 and 15), whereas the N-terminal region of
MSP58 (1–300) was unable to affect TEIF binding to the hTERT probe
(Fig. 5B, right, lanes 12 and 13), consistent with results of the luciferase
reporter assays (Fig. 3C). These ﬁndings suggest that the interaction be-
tween MSP58 and the TEIF results in the DNA-binding domain of TEIF
are masked and further repressed TEIF-mediated activation of hTERT
transcription. Next, we examined whether the expression of MSP58
prevented hTERT-binding activity of the endogenous TEIF in stable
MSP58-overexpressing HT1080 cells using a ChIP analysis. After formal-
dehyde cross-linking andprecipitation of chromatinwith an anti-TEIF or
Flag antibody, the precipitatedDNAwas PCR-ampliﬁedwith a set of spe-
ciﬁc primersﬂanking thehTERTproximal core promoter region (Fig. 5A).
As a control, TEIF clearly associatedwith the endogenous hTERTpromoter
(Fig. 5C, lanes 2 and 3). MSP58 binding to the hTERT promoter in HT1080Fig. 3.MSP58 represses TEIF-mediated activation of the hTERT promoter and telomerase activity
of TERTLuc800 or p-196 reporter construct, 50 ng of pRL-TK, 200 ng of a TEIF expression ve
-knockdown (500 ng of pSuper-MSP58 si-3 or si-5) plasmids, followed by a luciferase ass
Flag-MSP58, HA-TEIF, endogenous MSP58 and actin. Columns, mean of three independen
transfected with 500 ng of TERTLuc800, 50 ng of pRL-TK, 200 ng of HA-TEIF, together with 1
Flag-MSP581–300, or Fag-MSP58300–462), followed by luciferase reporter assays. Western blot sh
deviation of triplicatemeasurements. *p b 0.05; **p b 0.01. NS, non-signiﬁcant. D, the TEIF and i
Western blot analyses of the TEIF, MSP58, and actin proteins, and TRAP assays were performed
negative controlswere included. IC, internal control. The ImageJ (NIH) programwas used tome
(middle). Error bars denote one standard deviation of quadruplicate measurements. Right, HT1
the TEIF or control vectors, and TRAP assays were performed 48 h after transfection. WesternMSP58 clones 11 and 14 was also observed in a ChIP assay using an anti-
Flag antibody (Fig. 5C, lanes 4 and 5). Notably, the amount of TEIF bound
to the hTERT promoter signiﬁcantly decreased in HT1080 MSP58 clones
11 and 14 cells compared to parental and vector control cells (Fig. 5C,
lanes 4 and 5). The repression by MSP58 was not associated with a
change in the expression level of TEIF protein (data not shown). Togeth-
er, these results suggest thatMSP58 inhibits TEIF activity through a phys-
ical interaction, interfering with the ability of TEIF to interact with DNA.
These ﬁndings point to a novel mechanism whereby MSP58 represses
TEIF-mediated hTERT transactivation.
3.6. MSP58 suppresses TEIF-mediated promotion of cell proliferation
in vitro and in vivo
Telomerase or hTERT inhibition compromises sustained prolifera-
tion and tumorigenic ability of cancer cells [60,61]. To further evaluate
the effect of the MSP58–TEIF complex on hTERT gene regulation and
cellular proliferation, we ﬁrst established human HT1080 and 293T
cell lines that exhibited stable expression of ectopic HA-tagged TEIF.
HT1080 and 293T TEIF cells exhibited remarkable colonies in mono-
layers, and marked colony formation in soft agar compared to vector
control cells (Fig. 6A and Supplemental Fig. 3). These results indicate
that TEIF has pro-proliferative properties. To establish the functional
relationship between the MSP58/TEIF interaction and cell-growth con-
trol, HT1080 and 293T cells with stable expression of TEIFwere infected
with a retrovirus carrying a GFP-MSP58 or control vector. Protein ex-
pression was determined by Western blotting with anti-HA and anti-
GFP antibodies (Fig. 6A and Supplemental Fig. 3). MSP58 overexpres-
sion alone in HT1080 cells signiﬁcantly reduced the colony size in soft
agar and colony numbers in monolayers (Fig. 6A, middle and right). Re-
markably, colony numbers of HT1080 and 293T cells co-expressing TEIF
and MSP58 were lower than those in TEIF-expressing cells (Fig. 6A and
Supplemental Fig. 3). In cell cycle analysis, TEIF-overexpressing cells
showed a decrease in G1 and an increase in S populations relative to
control cells. Consistent with our previous study, a signiﬁcant decrease
in the number of G1 cells and a concomitant increase in S and G2/M
cells were seen in the MSP58-overexpressing cells (Fig. 6B). Lack of
sub-G1 suggested that MSP58 upregulation does not induce apoptosis
of HT1080 cells. Combining MSP58 and TEIF expression mainly
sustained an increase in S population. Further, we used an in vivo subcu-
taneous tumor formation assay to examine the proliferative ability of
MSP58- and TEIF-overexpressing cells in the mice. Fig. 6C (left) shows
the time course of the growth of tumors initiated by different HT1080
transfectants. As compared with control cells carrying empty vectors,
injecting mice with HT1080-MSP58 cells resulted in a signiﬁcantly
decreased in growth rate of tumors, whereas mice injected with
HT1080-TEIF cells showed signiﬁcantly increased tumor growth. The
growth kinetic of tumors in the MSP58/TEIF coexpression group was
similar to that of the tumors in the HT1080-MSP58 group. The tumors
were removed from each mouse on Day 24 and weighed. Consistently,
overexpression of TEIF signiﬁcantly increased solid tumormass, where-
as overexpression ofMSP58decreased solid tumormass comparedwith
the control group (Fig. 6C, middle). The tumor weight in the HT1080-
MSP58/TEIF xenografts was signiﬁcantly lower than that of the
HT1080-TEIF group. Notably, the hTERT protein level and telomerase. A and B, 293T and HT1080 cells were transiently transfected in 6-well plates with 500 ng
ctor (HA-TEIF), and the indicated amounts of MSP58-overexpressing (Flag-MSP58) or
ay 48 and 72 h post-transfection, respectively. The Western blot shows expression of
t experiments; bars, standard deviation. *p b 0.05; **p b 0.01. C, 293T cells were co-
00 ng of expression plasmids for either of the different MSP58 mutants (Flag-MSP58FL,
ows expression of HA-TEIF and Flag-MSP58FL or mutants. Error bars denote one standard
ndicated amounts ofMSP58 or control expression vectorswere transfected into 293T cells.
48 h after transfection (left). Positive 293T-cell extract control, and CHAPS lysis buffer for
asure the relative amounts of bands in the TRAP assays after normalization to a 36-bp band
080 parental, control vector, andMSP58 stable clone 11 and 14 cells were transfectedwith
blot analyses of TEIF and actin proteins.
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MSP58, compared to those expressing TEIF alone (Fig. 6A, left and C,
right). These results further substantiate the notion that MSP58 func-
tions as a negative TEIF coregulator in downregulating TEIF-mediated
hTERT expression and promoted cell proliferation.
4. Discussion
Regulation of hTERT gene expression by a variety of factors is crucial
for the progression and maintenance of human tumors [10]. In this
studywe showed thatMSP58 is an important regulator of hTERT expres-
sion. In summary, our results indicated that (i) ectopic expression of
MSP58 in both 293T and HT1080 cells resulted in decreased hTERT
transcription and telomerase activity, whereas knockdown of MSP58
exerted the opposite effect; (ii) MSP58 speciﬁcally suppressed TEIF-
mediated hTERT transactivation, telomerase activation, and cell growth-
promoting activity in vitro and in vivo; and (iii) this regulation wasmediated by MSP58 protein which interferes with the DNA-binding
activity of TEIF through interaction with the TEIF DNA-binding domain.
These ﬁndings provide insight into the mechanisms modulating hTERT
transcription and cell proliferation at the molecular level that involve
MSP58 and its interplay with TEIF.
MSP58 interacts with multiple proteins to exert distinct cellular
functions. In particular, MCRS2, an isoform of human MSP58, interacts
with a potent telomerase inhibitor, LPTS/PinX1 and hTERT [43]. MCRS2
inhibited telomerase activity in vitro, and long-term overexpression of
MCRS2 resulted in progressive telomere shortening. Here, we demon-
strated that MSP58 repressed telomerase activity by inhibiting TEIF-
mediated transactivation of the hTERT promoter (Fig. 3). Although a
direct interaction betweenMSP58 andhTERTwas not detected (Supple-
mental Fig. 2), identiﬁcation of MSP58 binding to the hTERT promoter
and modulation of hTERT expression by MSP58 indicate major control
points at the transcriptional level (Fig. 1). Our data indicate that pro-
tein–protein interactions between MSP58 and TEIF are signiﬁcant for
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several studies have shown thatMSP58 binds to individual transcription
factors, modulating their effects on target genes [40–42,44]. Our ChIP
assay indicated that MSP58 associates with the hTERT promoter
(Fig. 5C). However, using an EMSA, we did not observe binding of
MSP58 to the hTERT promoter (Fig. 5B). MSP58 family proteins lackDNA-binding domains and must therefore be recruited to DNA through
interactions with transcriptional regulators, most likely through an
interaction with TEIF. Accordingly, we propose that MSP58 participates
in the negative effect of TEIF on hTERT.
Another aspect that should be explored is the interaction be-
tween MSP58 and p53 or BRG1, a subunit of the SWI/SNF chromatin-
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577C.-C. Hsu et al. / Biochimica et Biophysica Acta 1843 (2014) 565–579remodeling complex, since they are also regulators of hTERT transcrip-
tion. p53 has been reported to repress hTERT expression and downreg-
ulate telomerase enzymatic activity [31,32]. Amutational analysis of the
hTERT core promoter suggested a mechanism of hTERT repression in
which p53 binds to Sp1 and renders it inaccessible to hTERT promoter
activation. In an additional study, Shats et al. showed that p53 induces
p21 to repress hTERT transcription via assembly of repressive E2F-
pocket protein complexes on an atypical E2F-binding site in the proxi-
mal core promoter [62]. Previous studies indicated that BRG1 functions
as a co-repressor of E2F-targeted gene transcription by associating with
Rb [63,64]. Interestingly, it was proposed that BRG1 functions as a
transactivator of the hTERT gene in human tumor cell lines and pos-
itively regulates exon-inclusion of hTERT transcripts, and therefore,
it contributes to maintaining active telomerase [65]. We previously
reported that the MSP58-BRG1-p53 trimeric complex is associated
with and is transactivated by the p21 promoter, and additionally,
MSP58-induced senescence is associated with activation of the p53/
p21 signaling pathway [48]. Deletion analyses in reporter assays im-
plied that the proximal region of the hTERT promoter was involved in
MSP58-mediated repression (Fig. 1C). This region contains consensus
binding sites for Sp1 and E2F transcription factors [11,12,16]. It is possi-
ble that upregulation of p53/p21 by MSP58 works on the promoter of
hTERT and suppresses it. MSP58 can thus play both a direct and indirect
role in the suppression of hTERT transcription.MSP58might also act as a
transcription modulator of E2F target genes such as hTERT by associat-
ing with BRG1. The combination of these upregulation and protein–
protein associations caused by binding ofMSP58 to the hTERT promoter
through p53, Brg1, or TEIF may decide the transcriptional state of
the hTERT gene. Furthermore, previous studies implicated histone
deacetylation in the transcriptional repression of the hTERT gene in nor-
mal cells [38]. Of note,MSP58 can forma complexwithMi-2β, a compo-
nent of the nucleosome-remodeling and deacetylase complex [42].
MCRS2 was puriﬁed as part of a complex containing the histone acetyl-
transferase males absent on the ﬁrst (MOF) in both humans and ﬂies
[45]. Additionally, the MSP58 protein is an integral component of
both the non-speciﬁc lethal (NSL) complex and the INO80 chromatin-
remodeling complex [46,47]. Therefore, it is likely that MSP58-mediated
repression of the hTERT promoter also occurs due to epigenetic histone
modiﬁcations and chromatin remodeling. Our studies have provided
clues for elucidating the mechanisms and functional signiﬁcance of
MSP58-mediated telomerase/hTERT regulation.
It should be noted that the negative regulation of hTERT transcription
by MSP58 was observed in some but not all cell types. Two different
shRNAs against MSP58 consistently induced increased levels of both
endogenous hTERT mRNA and protein in 293T, HT1080, and HCT116
cell lines compared to control Luc-shRNA cells (Fig. 1A and data not
shown). In contrast, MSP58 shRNAs suppressed levels of both hTERT
mRNA and protein in HeLa cell lines (data not shown). Thus, a proper
amount of MSP58 is important for regulating hTERT expression in
cells. The reason for this cell-type speciﬁcity is not yet known. The fact
that we did not detect an obvious difference in the expression of TEIF
in all the examined cells (data not shown) suggests that MSP58-
mediated suppression of the hTERT promoter might not be necessaryFig. 6.MSP58 suppresses TEIF-mediated promotion of cell proliferation in vitro and in vivo. A,
roviruses containing an EGFP or EGFP-MSP58 plasmid for 72 h and then split for the following a
assay, focus-formation assays, and soft-agar anchorage-independent growth (middle). For the f
were detected by staining cells with 2% methylene blue. For the soft-agar assay, cells were pla
Representative plates are shown. Data represent the average number of foci or colonies ± sta
B, MSP58 and TEIF regulate cell cycle progression. The HT1080-HA empty/GFP, HT1080-HA-TE
vested and stained with propidium iodide, followed by ﬂow cytometry. Each graph depicts ﬂuo
G1, S, and G2/M phases are listed within each graph. Bar plots summarize the percentages of
HT1080-HA empty/GFP-MSP58, and HT1080-HA-TEIF/GFP-MSP58 cells were injected subc
Tumor growth curves were determined by measuring the tumor volume every two days from
after injection. Tumor weight ofmice 24 days after injection (middle). Data aremean ± SD of 4
tumors were collected and processed for Western blot and telomerase activity (right). The TEI
trolled by a corresponding actin blot. The telomerase activity wasmeasured for 125 ng protein e
IC, internal control.for the interaction with this protein. Obviously, we could not exclude
the possibility that MSP58 operates on the hTERT gene by partnering
with other protein(s) in a different cell context; thus, its effect on
hTERT modulation is either positive or negative. In addition, by gene
expression array analysis, we identiﬁed several novel MSP58 target
genes known to regulate hTERT transcription, including E2F-1 and
E2F-5 (unpublished data). Interestingly, the effects of some target
genes (such as E2F-1) are known to act as the positive or negative reg-
ulators of hTERT transcription in different cellular systems, further
supporting the view of cell type speciﬁcity regarding MSP58 in hTERT
transcriptional regulation. Elucidation of the molecular basis of such
cell type-speciﬁc effects will require further investigation. Furthermore,
because up-regulation of telomerase activity is a common step in cell
immortalization, all cell lines amenable to the assays utilized here
have signiﬁcant detectable telomerase activity. We previously reported
that MSP58 expression was upregulated during replicative senescence
in normal human ﬁbroblasts [48]. It would be of interest to further
examine theMSP58-mediated hTERT transcriptional modulation in nor-
mal somatic cells.
Our work demonstrated that alternations (increases or decreases) in
the expression of MSP58 protein modulate hTERT expression. Notably,
our previous observations that long-term MSP58 gene silencing in
HeLa andHT1080 cells using siRNA induces apoptosis [48] are consistent
with recent reports [49,66]. Because hTERT expression is also necessary
for the survival of some cancer cells, it is likely that MSP58 siRNA-
induced apoptosis is at least in part due to dysregulation of hTERT tran-
scription. However, we cannot assume that all the cell growth effects
seen upon MSP58 depletion are due only to the dysregulation in hTERT
levels, since MSP58 previously has been shown to regulate cell cycle
progression [44,67]. The observed effects of MSP58 siRNAs on tumor
growth inhibition and apoptosis induction may be partially interpreted
by the fact that MSP58 is also a general transcription modulator that
controls multiple biologically important gene activities, and that knock-
down of MSP58 expression by siRNA may therefore block other cell
proliferation-associated genes under the inﬂuence of MSP58, in addi-
tion to activation of the hTERT promoter. For example, MSP58 or
MCRS2 has been implicated in regulating the expression of several
cyclins [44,48,67]. In addition, a recent study showed that MSP58 is re-
quired for spindle assembly and regulates the stability of kinetochore
spindles [68]. Our results add complexity to our knowledge of the regu-
lation of growth-related gene expression by MSP58.
Themechanism underlyingMSP58-mediated oncogenesis is incom-
pletely understood and its target genes essential for transformation
await further characterization. Identifying the hTERT as a target of
MSP58 contributes to our understanding of how this factor modulates
cell proliferation and cancer development. In this study, we report
that MSP58 represses telomerase activity through the inhibition of
TEIF-mediated transactivation of the hTERT promoter via direct TEIF
binding. TEIF, which was initially identiﬁed as a transactivator of the
hTERT gene, can stimulate telomerase activity [53]. TEIF can also upreg-
ulate the expression of DNA polymerase-β [69]. A recent study demon-
strated that the TEIF protein is localized on the centrosome and is
implicated in linking centrosome ampliﬁcation of DNA damage andHT1080 cells stably expressing the TEIF or a control empty vector were infected with ret-
ssays: immunoblotting for the TEIF,MSP58, and endogenous hTERT expression (left), TRAP
ocus-formation assay, cells were plated at a low density on dishes. After 2 weeks, colonies
ted in complete growth medium containing 0.3% agarose and overlaid with 0.6% agarose.
ndard deviation from three independent experiments performed in triplicate. **p b 0.01.
IF/GFP, HT1080-HA empty/GFP-MSP58, and HT1080-HA-TEIF/GFP-MSP58 cells were har-
rescent intensity versus cell count for about 20,000 total events. The percentages of cells in
cells in the G1, S, and G2/M phases. C, the HT1080-HA empty/GFP, HT1080-HA-TEIF/GFP,
utaneously into the back of SCID mice to initiate tumor formation (5 mice per group).
Day 8 after injection to Day 23 (left). Tumors were excised and photographed 24 days
0 samples from two experiments. *p b 0.05; **p b 0.01. The established HT1080 xenograft
F, MSP58 and hTERT levels were determined byWestern blot and equal loading was con-
xtract per lane using the TRAP assay. CHAPS lysis buffer alone served as a negative control.
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ous study reported that p78, an isoform ofMSP58, interacts and colocal-
izes with the Nde1, Su48, and δ-interacting protein A centrosomal
proteins, and may have a role in the maintenance of centrosome
homeostasis [49,50]. Similarly, we also observed that experimentally in-
duced MSP58 depletion, like TEIF depletion [70], induced centrosome
ampliﬁcation and aneuploidy [48]. The concurrence of centrosome
abnormalities and telomere dysfunction plays an important role in
generating chromosomal instability that is characteristically found in
neoplasia [71], but little is known about the mechanism linking these
two distinct cellular events. It is quite possible that the ways MSP58
exerts an inhibitory effect on cell growth are complex, through inter-
actingwith TEIF, may be prompted by a series of interchanges includ-
ing telomerase inhibition, telomere dysfunction, and centrosome
abnormalities.
We previously proposed thatMSP58 has both oncogenic and tumor-
suppressive properties [48]. Our previous study showed that MSP58-
driven oncogene induced senescence through the DNA damage re-
sponse pathway [48]. Combined with our current observations, this
raises the possibility that by inhibiting hTERT, MSP58 favors an un-
stable genomic state at early stages of transformation, which proba-
bly drives a mutagenic effect in favor of the development of a fully
transformed phenotype. Alternatively, MSP58-triggered inhibition
of telomerase/hTERT may reﬂect potential anti-tumor activity of
MSP58. Overexpression of MSP58 increases S/G2M phases and
decreases tumorigenicity of HT1080 cells. MSP58 might have other,
as yet unidentiﬁed functions that contribute to its tumor suppressing
effect. Various levels of TEIF expression have been reported in many
tumor types [72,73]. MSP58 may act, in part, by regulating the onco-
genic potential of TEIF through hTERT transcriptional inhibition. Our
ﬁndings provide insight into one newly identiﬁed mechanism of
telomerase/hTERT modulation by pointing to MSP58 as a potential
repressor, thereby facilitating our understanding of the role of
MSP58 in tumorigenesis.5. Conclusion
We show in this report that MSP58 protein can function as a nega-
tive regulator of hTERT transcription, and that interaction between
MSP58 and TEIF may be involved in this regulation. MSP58 inhibits
TEIF-mediated hTERT transactivation, telomerase activation, and cell
growth-promoting activity in vitro and in vivo. Identiﬁcation of the
function of MSP58 in telomerase/hTERT regulation provides new
insights for understanding the role of MSP58 in carcinogenesis.Acknowledgements
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